Henry J Fuchs Mirati Therapeutics, Inc. (MRTX) insider trading activity

Henry J Fuchs is of Mirati Therapeutics, Inc.. Currently has a direct ownership of 10,465 shares of MRTX, which is worth approximately $0. The most recent transaction as insider was on Jan 20, 2023, when has been sold 4,444 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.5K

0% 3M change

0% 12M change

Total Value Held $0

HENRY J FUCHS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 20 2023	BUY Grant, award, or other acquisition	-	4,444 Added 29.81%	10,465 Common Stock
Feb 11 2022	SELL Open market or private sale	$1,161,930 $105.63 p/Share	11,000 Reduced 64.63%	6,021 Common Stock
Feb 11 2022	BUY Exercise of conversion of derivative security	$225,940 $20.54 p/Share	11,000 Added 39.26%	17,021 Common Stock
Jan 14 2022	BUY Grant, award, or other acquisition	-	2,546 Added 29.72%	6,021 Common Stock
Jan 15 2021	BUY Grant, award, or other acquisition	-	1,475 Added 29.8%	3,475 Common Stock
Dec 15 2020	SELL Open market or private sale	$2,343,300 $234.33 p/Share	10,000 Reduced 83.33%	2,000 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	$205,400 $20.54 p/Share	10,000 Added 45.45%	12,000 Common Stock

Also insider at

BMRN

BIOMARIN PHARMACEUTICAL INC Healthcare

President, Worldwide R&D

HJF

Henry J Fuchs

San Rafael, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Mirati Therapeutics, Inc. insider buys or sells MRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Mirati Therapeutics, Inc.

Track Activities on MRTX

Account